Becton, Dickinson & Co. (BDX)
187.31
-0.21
(-0.11%)
USD |
NYSE |
Sep 03, 14:39
Becton, Dickinson Cash from Investing (Quarterly) : -228.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -228.00M |
| March 31, 2026 | -192.00M |
| December 31, 2025 | -183.00M |
| September 30, 2025 | -494.00M |
| June 30, 2025 | -337.00M |
| March 31, 2025 | -192.00M |
| December 31, 2024 | 204.00M |
| September 30, 2024 | -3.937B |
| June 30, 2024 | -288.00M |
| March 31, 2024 | -1.056B |
| December 31, 2023 | -233.00M |
| September 30, 2023 | 137.00M |
| June 30, 2023 | -329.00M |
| March 31, 2023 | -233.00M |
| December 31, 2022 | -291.00M |
| September 30, 2022 | -2.004B |
| June 30, 2022 | -1.513B |
| March 31, 2022 | 969.00M |
| December 31, 2021 | -682.00M |
| September 30, 2021 | -694.00M |
| June 30, 2021 | -323.00M |
| March 31, 2021 | -433.00M |
| December 31, 2020 | -430.00M |
| September 30, 2020 | -327.00M |
| June 30, 2020 | -363.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -255.00M |
| December 31, 2019 | -287.00M |
| September 30, 2019 | -441.00M |
| June 30, 2019 | -330.00M |
| March 31, 2019 | -269.00M |
| December 31, 2018 | 299.00M |
| September 30, 2018 | -560.00M |
| June 30, 2018 | 200.00M |
| March 31, 2018 | -58.00M |
| December 31, 2017 | -15.32B |
| September 30, 2017 | -347.00M |
| June 30, 2017 | -381.00M |
| March 31, 2017 | -203.00M |
| December 31, 2016 | 48.00M |
| September 30, 2016 | -351.00M |
| June 30, 2016 | -148.00M |
| March 31, 2016 | -25.00M |
| December 31, 2015 | -145.00M |
| September 30, 2015 | -315.00M |
| June 30, 2015 | -174.00M |
| March 31, 2015 | -8.197B |
| December 31, 2014 | 368.00M |
| September 30, 2014 | -218.00M |
| June 30, 2014 | -232.00M |
| March 31, 2014 | -231.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -673.00M |
| Boston Scientific Corp. | -1.956B |
| Stryker Corp. | -639.00M |
| Baxter International, Inc. | -117.00M |
| Intuitive Surgical, Inc. | -26.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 652.00M |
| Cash from Financing (Quarterly) | -651.00M |
| Free Cash Flow | 2.533B |
| Free Cash Flow Per Share (Quarterly) | 1.850 |
| Free Cash Flow to Equity (Quarterly) | 980.00M |
| Free Cash Flow to Firm (Quarterly) | 616.70M |
| Free Cash Flow Yield | 4.79% |